Home Tags Pharmaceutical Industry

Pharmaceutical Industry Related Content

THC in CBD, EUMCA

EUMCA: Limit of 0.2% THC in CBD products should not change

Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
medical cannabis

How are different types of medical cannabis working for different diseases?

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.
pain medicine

How cannabinoids can be used as pain medicine

Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.
access to medicinal cannabis, trevor jones

The EUMCA: Pioneering access to medicinal cannabis

Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
cannabinoid research

Expanding the portfolio of rigorous cannabinoid research with new funding opportunities

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, discusses new funding opportunities for cannabinoid research.
biochemistry

How does research in biochemistry fit into the wider goals of the NIH?

Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.
cytochromes p450

Cytochromes P450: Chemistry for drugs, metabolism, and beyond

Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.
medicinal cannabis from Israel

The export of medicinal cannabis from Israel

Kathleen Denoodt shares with us what we need to know about the export of medicinal cannabis from Israel.
Gyrase and topoisomerase IV

Gyrase and topoisomerase IV: Repurposing old targets for new antibacterials

Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
clinical trials

A vision on remote decentralised clinical trials

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, shares a vision for remote decentralised clinical trials.
imaging biomarkers

Oncology: Imaging biomarkers and the Alberta Radiopharmaceutical Collaboration

Dr Frank Wuest, Professor at Department of Oncology - University of Alberta, sheds light on the imaging biomarkers and the Alberta Radiopharmaceutical Collaboration in this special oncology focus.
influenza virus

Enduring research: The constant threat of influenza virus outbreaks

Here, experts Stephan Pleschka, Oliver Planz and Stephan Ludwig walk us through the constant threat of influenza virus outbreaks and the benefit of enduring research in antiviral drug development.
european cannabinoid, ilesol

Ilesol Pharmaceuticals: First European cannabinoid à la carte company

Here, Ilesol Pharmaceuticals discuss how they became the first European cannabinoid company to unlock this sector of the market.
biomedical innovations

Targeted policy support for emerging biomedical innovations

Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
treat epilepsy

Can cannabidiol (CBD) treat epilepsy?

Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.
drug testing

Stop drug testing and start impairment testing

A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
detecting pain, pain

Chemistry: Microfluidic devices for detecting pain

Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
SARS-CoV-2

Scientists design novel chemical compounds using AI to combat SARS-CoV-2

Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
curing hepatitis C

Drugs used for curing hepatitis C might also help against COVID-19

Several drugs used for curing hepatitis C have been identified as potential candidates to treat COVID-19, according to research conducted using the MOGON II supercomputer at Johannes Gutenberg University Mainz.
metals in cannabis

Measuring heavy metals in cannabis and hemp

Here, Robert Thomas, Principal Consultant, Scientific Solutions, highlights the importance of measuring metals in cannabis and hemp.

Follow Open Access Government